Literature DB >> 6120711

Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.

R Lochan, B Silke, S H Taylor.   

Abstract

1 The speed of onset of the pharmacodynamic activity of intravenous propranolol, practolol, oxprenolol and metoprolol was determined, using attenuation of isoprenaline-induced tachycardia as the end-point, in 16 patients with clinically coronary heart disease. 2 Antagonism was evident within 15 s of injection into the central circulation of all four drugs. The time to maximum attenuation of isoprenaline tachycardia was significantly more rapid with propranolol and oxprenolol than with practolol and metoprolol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6120711      PMCID: PMC1401967          DOI: 10.1111/j.1365-2125.1981.tb01295.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Plasma concentrations and the time-course of beta blockade due to propranolol.

Authors:  D G McDevitt; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

2.  Detection of carriers of inherited disorders.

Authors:  R G Davidson
Journal:  Birth Defects Orig Artic Ser       Date:  1976

3.  Withdrawal of propranolol and myocardial infarction.

Authors:  R G Diaz; J C Somberg; E Freeman; B Levitt
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

4.  Evaluation of isoproterenol as a method of stress testing.

Authors:  D T Combs; C M Martin
Journal:  Am Heart J       Date:  1974-06       Impact factor: 4.749

5.  Effect of isoproterenol on the abnormal T wave.

Authors:  F S Daoud; B Surawicz; L S Gettes
Journal:  Am J Cardiol       Date:  1972-12       Impact factor: 2.778

6.  Electrocardiographic effects of isoprenaline in normal subjects and patients with coronary atherosclerosis.

Authors:  H Wexler; J Kuaity; E Simonson
Journal:  Br Heart J       Date:  1971-09

7.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

8.  Coronary artery syndromes after sudden propranolol withdrawal.

Authors:  E L Alderman; D J Coltart; G E Wettach; D C Harrison
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

Review 9.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  Propranolol rebound--a retrospective study.

Authors:  R A Shiroff; J Mathis; R Zelis; D W Schneck; J D Babb; D M Leaman; A H Hayes
Journal:  Am J Cardiol       Date:  1978-04       Impact factor: 2.778

View more
  8 in total

1.  Comparison of the acute haemodynamic effects of bopindolol and propranolol at rest and during supine exercise.

Authors:  P Fitscha; W Meisner; B Tiso
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  The use of propranolol in rapid sequence anaesthetic induction: optimal time interval for pretreatment.

Authors:  A M Safwat; D L Fung; D C Bilton
Journal:  Can Anaesth Soc J       Date:  1984-11

3.  Haemodynamic dose-response effects of i.v. metoprolol in coronary heart disease.

Authors:  W G Hendry; B Silke; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

Authors:  B Silke; G I Nelson; R C Ahuja; R C Okoli; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?

Authors:  B Silke; S P Verma; R C Ahuja; M Hussain; M Hafizullah; G Reynolds; G I Nelson; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris.

Authors:  B Silke; S P Verma; M Hussain; G I Nelson; R C Okoli; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

7.  Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.

Authors:  B Silke; M A Frais; S P Verma; G Reynolds; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  The impact of transposable elements on tomato diversity.

Authors:  Marisol Domínguez; Elise Dugas; Médine Benchouaia; Basile Leduque; José M Jiménez-Gómez; Vincent Colot; Leandro Quadrana
Journal:  Nat Commun       Date:  2020-08-13       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.